ESPR — ESPERION THERAPEUTICS INC NE
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 202 SEC-registered investment managers reported holding ESPR (ESPERION THERAPEUTICS INC NE) in their latest 13F filings, with a combined reported value of $658.86M across 212.17M shares. That is -6.9% by share count (-7.66M shares) versus the previous quarter, while reported value moved +6.7%. Ownership is concentrated: the five largest holders account for 37.2% of reported value and the top ten for 52.3%.
Compared with the prior quarter, 68 opened new positions, 49 added to existing stakes, 51 trimmed, 83 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ESPERION THERAPEUTICS INC NE (ESPR) include TENOR CAPITAL MANAGEMENT Co., L.P., GLAZER CAPITAL, LLC, BlackRock Inc, ranked by reported 13F value among the 431 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 1 | 2.34K | $7.40K | +0.0% |
| Q2 2026 | 202 | 212.17M | $658.86M | -6.9% |
| Q1 2026 | 217 | 188.34M | $515.50M | +7.9% |
| Q4 2025 | 208 | 166.33M | $614.67M | +49.8% |
| Q3 2025 | 201 | 118.24M | $298.48M | +2.5% |
| Q2 2025 | 169 | 105.64M | $125.95M | -0.5% |
| Q1 2025 | 195 | 121.37M | $12.37B | -11.2% |
| Q4 2024 | 201 | 139.72M | $279.38M | -23.8% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+49.8%).
Top Institutional Holders (Q3 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.34K | $7.40K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 22.42M | $70.84M | 2.11% | New | |
| 22.13M | $69.92M | 0.00% | Add | |
| 11.43M | $36.11M | 0.00% | Add | |
| 11.16M | $35.26M | 21.69% | New | |
| 10.38M | $32.80M | 0.01% | Add | |
| 7.13M | $22.52M | 0.04% | Reduce | |
| 6.63M | $20.96M | 0.00% | New | |
| 6.63M | $20.96M | 0.00% | Add | |
| 6.05M | $19.11M | 0.29% | New | |
| 5.00M | $15.80M | 0.77% | New | |
| 4.65M | $14.71M | 0.05% | New | |
| 4.61M | $14.58M | 0.00% | Add | |
| 4.43M | $14.00M | 12.65% | New | |
| 3.88M | $12.28M | 2.04% | Hold | |
| 3.84M | $12.12M | 0.01% | Reduce | |
| 3.30M | $10.43M | 4.54% | New | |
| 3.59M | $9.83M | 0.00% | Add | |
| 2.96M | $9.34M | 0.64% | New | |
| 2.88M | $9.10M | 0.06% | New | |
| 2.59M | $8.18M | 0.40% | New | |
| 2.47M | $7.81M | 0.00% | Reduce | |
| 2.32M | $7.34M | 0.00% | Add | |
| 2.32M | $7.32M | 1.06% | New | |
| 2.23M | $7.03M | 0.00% | Add | |
| 2.23M | $7.03M | 0.01% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.85M | $48.92M | 0.00% | Add | |
| 15.77M | $43.21M | 0.29% | Add | |
| 11.39M | $31.22M | 0.49% | Reduce | |
| 10.57M | $28.96M | 0.60% | Add | |
| 10.43M | $28.59M | 0.00% | New | |
| 9.46M | $25.92M | 0.04% | Add | |
| 7.08M | $19.39M | 0.03% | Add | |
| 7.06M | $19.33M | 0.00% | Add | |
| 6.54M | $17.92M | 0.01% | Reduce | |
| 6.54M | $17.92M | 0.04% | Reduce | |
| 5.96M | $16.32M | 0.00% | Add | |
| 4.40M | $12.06M | 1.64% | Add | |
| 4.29M | $11.76M | 0.01% | Add | |
| 3.93M | $10.77M | 0.21% | New | |
| 3.89M | $10.66M | 2.15% | Reduce | |
| 3.61M | $9.90M | 0.00% | Hold | |
| 3.53M | $9.68M | 0.00% | New | |
| 3.30M | $9.04M | 1.88% | New | |
| 2.74M | $7.50M | 0.00% | Reduce | |
| 2.63M | $7.20M | 0.07% | Reduce | |
| 2.63M | $7.20M | 0.07% | Reduce | |
| 2.41M | $6.60M | 0.00% | Reduce | |
| 2.14M | $5.85M | 0.00% | Add | |
| 2.10M | $5.76M | 0.00% | Add | |
| 2.07M | $5.68M | 0.11% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.68M | $65.42M | 0.00% | Add | |
| 14.95M | $55.30M | 0.00% | Add | |
| 11.90M | $44.04M | 1.09% | Add | |
| 9.45M | $34.95M | 0.21% | Add | |
| 6.90M | $25.54M | 0.01% | Add | |
| 6.90M | $25.54M | 0.05% | Add | |
| 5.97M | $22.07M | 0.47% | New | |
| 5.93M | $21.94M | 0.00% | Add | |
| 5.74M | $21.23M | 0.00% | Add | |
| 5.47M | $20.24M | 0.03% | Add | |
| 4.74M | $17.55M | 0.04% | Add | |
| 4.39M | $16.25M | 3.17% | Add | |
| 4.00M | $14.80M | 3.58% | Add | |
| 3.93M | $14.55M | 0.01% | Add | |
| 3.93M | $14.55M | 0.02% | Add | |
| 3.85M | $14.25M | 0.72% | New | |
| 3.61M | $13.36M | 0.00% | Reduce | |
| 3.60M | $13.33M | 0.14% | Add | |
| 3.60M | $13.33M | 0.14% | Add | |
| 3.51M | $13.00M | 0.00% | Reduce | |
| 3.51M | $12.97M | 0.03% | Add | |
| 2.85M | $10.54M | 0.00% | Add | |
| 2.19M | $8.12M | 0.01% | Add | |
| 2.14M | $7.93M | 0.18% | New | |
| 2.09M | $7.75M | 0.01% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.83M | $39.31M | 0.00% | Add | |
| 12.09M | $32.04M | 0.00% | Add | |
| 9.75M | $25.84M | 0.47% | Reduce | |
| 7.06M | $18.71M | 0.10% | Reduce | |
| 4.75M | $12.59M | 0.00% | Add | |
| 12.44K | $12.42M | 0.49% | Hold | |
| 4.48M | $11.87M | 0.00% | Add | |
| 4.06M | $10.75M | 0.00% | Add | |
| 3.71M | $9.83M | 0.00% | Add | |
| 8.40M | $8.34M | 0.36% | Add | |
| 3.00M | $7.95M | 2.60% | New | |
| 2.52M | $6.68M | 0.01% | Reduce | |
| 2.29M | $6.08M | 0.06% | New | |
| 2.29M | $6.08M | 0.06% | New | |
| 2.24M | $5.93M | 0.01% | Add | |
| 1.91M | $5.06M | 0.01% | Reduce | |
| 1.85M | $4.90M | 0.00% | Add | |
| 1.71M | $4.53M | 0.00% | Add | |
| 1.50M | $3.98M | 0.34% | New | |
| 1.25M | $3.30M | 0.00% | Reduce | |
| 3.00M | $3.04M | 0.66% | Reduce | |
| 974.86K | $2.58M | 0.00% | Add | |
| 974.86K | $2.58M | 0.00% | Add | |
| 945.49K | $2.51M | 0.00% | Add | |
| 909.23K | $2.41M | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.71M | $14.48M | 0.00% | Add | |
| 12.44K | $12.20M | 0.59% | Hold | |
| 11.72M | $11.53M | 0.00% | Add | |
| 10.34M | $10.18M | 0.05% | Reduce | |
| 9.95M | $9.80M | 0.18% | Add | |
| 9.68M | $9.53M | 2.58% | Add | |
| 7.50K | $7.42M | 6.94% | Hold | |
| 5.31M | $5.21M | 0.01% | Add | |
| 4.58M | $4.51M | 0.00% | Add | |
| 3.76M | $3.70M | 0.00% | Reduce | |
| 3.00M | $2.95M | 2.18% | Hold | |
| 2.46K | $2.50M | 0.26% | Reduce | |
| 2.40M | $2.37M | 0.12% | Hold | |
| 2.09M | $2.06M | 0.00% | Reduce | |
| 1.83M | $1.80M | 0.00% | Reduce | |
| 1.78M | $1.76M | 0.00% | Add | |
| 1.75M | $1.73M | 0.04% | Reduce | |
| 1.54M | $1.51M | 0.00% | Add | |
| 1.50M | $1.48M | 0.01% | Hold | |
| 1.46M | $1.43M | 0.03% | Add | |
| 1.17M | $1.15M | 0.00% | Add | |
| 1.11M | $1.10M | 0.00% | Add | |
| 1.06M | $1.04M | 0.00% | Reduce | |
| 836.34K | $822.96K | 0.00% | Reduce | |
| 798.75K | $786.29K | 0.00% | Reduce |
New Positions (Q2 2026)
- GLAZER CAPITAL, LLC 22.42M sh · $70.84M
- Trium Capital LLP 11.16M sh · $35.26M
- GEODE CAPITAL MANAGEMENT, LLC 6.63M sh · $20.96M
- AQR Arbitrage LLC 6.05M sh · $19.11M
- ODDO BHF ASSET MANAGEMENT SAS 5.00M sh · $15.80M
- Balyasny Asset Management 4.65M sh · $14.71M
- Beryl Capital Management LLC 4.43M sh · $14.00M
- PSquared Asset Management AG 3.30M sh · $10.43M
- NEXPOINT ASSET MANAGEMENT, L.P. 2.96M sh · $9.34M
- GABELLI FUNDS LLC 2.88M sh · $9.10M
- TIG Advisors, LLC 2.59M sh · $8.18M
- GABELLI & Co INVESTMENT ADVISERS, INC. 2.32M sh · $7.32M
Fully Exited (vs previous quarter)
- Two Seas Capital LP sold 11.39M sh · $31.22M
- ORBIMED ADVISORS LLC sold 10.57M sh · $28.96M
- STATE STREET CORP sold 7.06M sh · $19.33M
- D. E. Shaw & Co sold 6.54M sh · $17.92M
- D. E. Shaw & Co., Inc. sold 6.54M sh · $17.92M
- AIGH Capital Management LLC sold 4.40M sh · $12.06M
- ARMISTICE CAPITAL, LLC sold 3.93M sh · $10.77M
- Privium Fund Management B.V. sold 3.30M sh · $9.04M
- Royce & Associates sold 2.63M sh · $7.20M
- ROYCE & ASSOCIATES LP sold 2.63M sh · $7.20M
- Caption Management, LLC sold 2.07M sh · $5.68M
- Eversept Partners, LP sold 1.74M sh · $4.76M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allworth Financial LP | 2.34K | 2.34K | 3.37K | 3.45K | 1.00K | 1.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Context Capital Management, LLC | — | — | — | — | 12.44K | 12.44K | 12.44K | — | 47.88K | 51.25K | 38.40K | 17.85M | 17.85K | — | — | — | — | — | — | — |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | — | — | — | — | — | — | — | — | — | 19.00M | 19.00M | 19.00M | — | — | — | — | — | — | — |
| WHITEBOX ADVISORS LLC | — | — | — | — | — | — | — | — | 30.18K | 23.85M | 16.85M | 16.85M | 16.85M | — | — | — | — | — | — | — |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | — | — | — | 254.26K | 254.26K | 254.26K | 254.26K | 254.26K | 254.26K | 18.50M | 22.47M | 77.10K | — | — | — | — | — | — | — |
| GLAZER CAPITAL, LLC | — | 22.42M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | — | 22.13M | 17.85M | 17.68M | 14.83M | 14.71M | 14.49M | 14.24M | 18.05M | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 14.95M | 12.09M | 11.72M | 11.49M | 11.72M | 13.04M | 10.82M | 8.83M | 5.14M | 4.74M | 4.26M | 4.32M | 4.26M | 4.04M | 4.30M | 4.49M | 3.76M |
| WASATCH ADVISORS LP | — | 1.93M | 15.77M | 9.45M | 7.06M | 10.34M | 10.93M | 24.48M | 23.35M | 16.86M | 9.13M | 8.89M | 11.53M | — | — | — | — | — | — | — |
| PenderFund Capital Management Ltd. | — | 3.88M | 3.89M | 4.39M | 3.00M | 9.68M | 3.00M | — | 40.43M | 40.43M | 40.43M | 41.03M | 41.03M | — | — | — | — | — | — | — |
| Two Seas Capital LP | — | — | 11.39M | 11.90M | 9.75M | 9.95M | 6.93M | 5.32M | 5.32M | 5.74M | 4.17M | 17.27M | 7.67M | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | — | — | 10.57M | 5.97M | — | — | — | — | — | — | 13.71M | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | — | 11.43M | 10.43M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Trium Capital LLP | — | 11.16M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | — | 10.38M | 2.41M | 2.85M | 1.71M | 798.75K | 1.53M | 2.75M | 1.31M | 916.01K | 3.36M | 1.06M | 1.18M | 825.71K | 701.16K | 728.34K | 465.80K | 261.56K | 369.51K | 287.27K |
| Indaba Capital Management, L.P. | — | — | — | — | — | 3.00M | 3.00M | 3.00M | 33.75M | 1.00M | — | — | — | — | — | — | — | — | — | — |
| Bellevue Group AG | — | — | — | — | — | — | 9.69M | 9.94M | 9.94M | 9.94M | 9.94M | 4.20M | 4.20M | — | — | — | — | — | — | — |
| Two Sigma Investments | — | 7.13M | 9.46M | 4.74M | 2.24M | 1.83M | 2.73M | 3.54M | 3.63M | 4.07M | 3.98M | 2.33M | 1.46M | 1.18M | 1.06M | 1.54M | 1.07M | 382.40K | 139.90K | 342.65K |
| D. E. Shaw & Co | — | — | 6.54M | 6.90M | 208.63K | — | 275.71K | 251.59K | 99.57K | 382.49K | 5.14M | 1.21M | — | — | — | — | 351.04K | 703.48K | 637.44K | 896.97K |
| D. E. Shaw & Co., Inc. | — | — | 6.54M | 6.90M | 208.63K | — | 275.71K | 251.59K | 99.57K | 382.49K | 5.14M | 1.21M | — | — | — | — | — | — | — | — |
FAQ
Which funds hold ESPR?
As of 2026-Q2, 202 institutional funds reported holding ESPR (ESPERION THERAPEUTICS INC NE) in SEC 13F filings, with a combined reported value of $658.86M.
How many shares of ESPR do institutions own?
13F filers reported 212.17M shares of ESPR, worth $658.86M in aggregate at the end of 2026-Q2.
Is institutional ownership of ESPR rising or falling?
Share counts moved -6.9% versus the prior quarter — distribution.
Who are the top institutional holders of ESPR?
The largest 13F holders are TENOR CAPITAL MANAGEMENT Co., L.P., GLAZER CAPITAL, LLC, BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ESPERION THERAPEUTICS INC NE?
The major shareholders of ESPERION THERAPEUTICS INC NE (ESPR) by reported 13F value are TENOR CAPITAL MANAGEMENT Co., L.P., GLAZER CAPITAL, LLC, BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 431 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.